Agenda

April 24, 2009

Recent Advances in the Treatment of Lung, Head/Neck Cancers Hummelstown, PA ,April 24, 2009
7:30 AM	Registration and Breakfast
8:25 AM	Welcome and Introductions	Chandra P. Belani, MD
State of the Art and Targeted Therapies Chair: Chandra P. Belani, MD
8:30 AM	Advanced Non Small-Cell Lung Cancer: Changes in Treatment Paradigm	Chandra P. Belani, MD
9:00 AM	Other Vascular Endothelial Growth Factor Targeting Agents Including Sutent, Sorafenib and Trial Designs	George Simon, MD
9:30 AM	Optimizing the Use of Epidermal Growth Factor, Targeting Agents-Tyrosin kinase Inhibitors and Monoclonal Antibodies	Suresh Ramalingam, MD
10:00AM	Panel Discussion
10:20 AM	BREAK
Combined Modality Therapy and Recurrent Disease: Lung, Head & Neck Cancers Session Chair: Suresh Ramalingam, MD
10:30 AM	Combined Modality Therapy of Lung, Head/Neck Cancers	Walter Curran, MD
11:00 PM	Recurrent Non Small-Cell Lung Cancer: Second Line Therapy - Standard of Care and Emerging Agents	Suresh Ramalingam, MD
11:30 AM	Panel Discussion
11:50 AM	LUNCH
Novel Therapeutics on the Horizon: Lung, Head & Neck Cancers Chair: Chandra P. Belani, MD
12:50 PM	New Systemic Therapies for Head/Neck Cancers	Corey Langer, MD
1: 20 PM	Proteasome Inhibitors, HDAC Inhibitors and Novel Taxanes in Treatment of Lung Cancer	Chandra P. Belani, MD
1:50 PM	Panel Discussion
2:10 PM	Closing Remarks & Adjourn	Chandra P. Belani, MD